Found: 22
Select item for more details and to access through your institution.
Necrobiotic xanthogranuloma, a rare complication of a persistently high paraprotein.
- Published in:
- 2010
- By:
- Publication type:
- Other
Peripheral blood alterations in a patient with infectious mononucleosis.
- Published in:
- 2010
- By:
- Publication type:
- Other
The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 3, doi. 10.1111/j.1365-2141.2010.08104.x
- By:
- Publication type:
- Article
Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 9, doi. 10.1111/j.1365-2141.2010.08140.x
- By:
- Publication type:
- Article
Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 21, doi. 10.1111/j.1365-2141.2009.07977.x
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance: a consensus statement.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 28, doi. 10.1111/j.1365-2141.2010.08207.x
- By:
- Publication type:
- Article
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 39, doi. 10.1111/j.1365-2141.2010.08162.x
- By:
- Publication type:
- Article
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 46, doi. 10.1111/j.1365-2141.2010.08175.x
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1–2 study.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 58, doi. 10.1111/j.1365-2141.2010.08193.x
- By:
- Publication type:
- Article
A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 72, doi. 10.1111/j.1365-2141.2010.08211.x
- By:
- Publication type:
- Article
Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 83, doi. 10.1111/j.1365-2141.2010.08196.x
- By:
- Publication type:
- Article
Purification of FANCD2 sub-complexes.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 88, doi. 10.1111/j.1365-2141.2010.08217.x
- By:
- Publication type:
- Article
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 93, doi. 10.1111/j.1365-2141.2010.08214.x
- By:
- Publication type:
- Article
NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 102, doi. 10.1111/j.1365-2141.2010.08195.x
- By:
- Publication type:
- Article
Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38<sup>+</sup>CD49d<sup>+</sup> chronic lymphocytic leukaemia cells.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?
- Published in:
- 2010
- By:
- Publication type:
- Letter
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Diagnosis of severe Type 1 Gaucher’s disease before irreversible damage occurs : is HDL cholesterol the answer?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study.
- Published in:
- 2010
- By:
- Publication type:
- Letter
A dodecapeptide deduced from cytokeratin sequence strongly enhances uPA/tPA-mediated plasminogen activation.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood.
- Published in:
- 2010
- By:
- Publication type:
- Letter